OGX-133

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOGX-133
Drug Alias NameOGX-133
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor binding protein V inhibitors
TargetsInsulin-like growth factor binding protein V
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOncoGenex Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncoGenex Technologies Inc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A